Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Physician Resources

Physician Education

Science of Safety Video

In 2010 ChristianaCare embarked on a national initiative called “On the CUSP: Stop Hospital-Acquired Infections,” led by Peter Pronovost, M.D., Ph.D., of the Johns Hopkins’ Center for Innovation in Quality Patient Care. CUSP, or Comprehensive Unit-Based Safety Program, consists of unit-based teams (CCHS has 7 currently: MICU, WICU, SCCC, CVICU, CICU, 2E and OR), each with physician and nursing champions, infection prevention, and an executive champion as well as many other front-line staff. One of the overarching goals of the program is to change the way health care systems think and communicate about patient safety (infections as well as other safety issues) and to adopt a culture in which every provider feels equally empowered to speak up about potential patient safety issues.

To that end, On the CUSP has produced a “Science of Safety” video featuring Dr. Pronovost that we are encouraging every ChristianaCare employee and Medical-Dental Staff member to view. This is meant to provide the very basic ground work upon which we can build and expand the CUSP program. We feel that it is critically important for all members of the health care team – physicians, nurses, and ancillary staff – to view this material. The video is approximately 30-minutes long but we feel that this important material is vital information for our health care team.

Dr. Pronovost biography:
Peter Pronovost, M.D., Ph.D., is a practicing anesthesiologist and critical care physician, teacher, researcher, and international patient safety leader. Dr. Pronovost is a Professor in the Johns Hopkins University School of Medicine (Departments of Anesthesiology and Critical Care Medicine, and Surgery); in the Bloomberg School of Public Health (Department of Health Policy and Management) and in the School of Nursing. He is also Medical Director for the Center for Innovation in Quality Patient Care, which supports quality and safety efforts at the Johns Hopkins Hospitals. In 2003, Dr. Pronovost established the Quality and Safety Research Group to advance the science of safety. Dr. Pronovost and his research team are dedicated to improving health care through methods that are scientifically rigorous, but feasible at the bedside. Dr. Pronovost holds a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He is co-Principal Investigator of the “On the CUSP: Stop HAI” program.